Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

To assess safety, reactogenicity & immunogenicity of a booster dose of pneumococcal conjugate vaccine, co-admin with GSK Biologicals’ MMRV vaccine in children (2nd yr of life) primed with the pneumococcal conjugate vaccine in study 105553.
Pneumococcal Polysaccharide Conjugate Vaccine (Adsorbed)
107706
NCT00370227
Infections, Streptococcal
Phase 3
 
An annotated case report form is not available for this study. A blank case report form will be provided.
September 2013

Powered by ideaPoint, Inc.